Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

The fatigue impact scale (FIS) was developed to improve our understanding of the effects of fatigue on quality of life. The FIS examines patients' perceptions of the functional limitations that fatigue has caused over the past month. FIS items reflect perceived impact on cognitive, physical, and psychosocial functioning. This study compared 145 patients referred for investigation of chronic fatigue (ChF) with 105 patients with multiple sclerosis (MS) and 34 patients with mild hypertension (HT). Internal consistency for the FIS and its three subscales was > .87 for all analyses. Fatigue impact was highest for the ChF group although the MS group's reported fatigue also exceeded that of the HT group. Discriminant function analysis correctly classified 80.0% of the ChF group and 78.1% of the MS group when these groups were compared. This initial validation study indicates that the FIS has considerable merit as a measure of patient's attribution of functional limitations to symptoms of fatigue.

[1]  T. J. Murray,et al.  Amantadine Therapy for Fatigue in Multiple Sclerosis , 1985, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[2]  J. Read,et al.  Measuring overall health: an evaluation of three important approaches. , 1987, Journal of chronic diseases.

[3]  S. Cullen,et al.  Development of a measure of symptoms in chronic fatigue syndrome: The profile of fatigue-related symptoms(pfrs) , 1992 .

[4]  G. Guyatt,et al.  Measuring quality of life in clinical trials: a taxonomy and review. , 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[5]  D. Wood,et al.  Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome. , 1988, JAMA.

[6]  M. Lorr,et al.  Manual for the Profile of Mood States , 1971 .

[7]  N. Larocca,et al.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. , 1989, Archives of neurology.

[8]  D. Klonoff Chronic fatigue syndrome. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  G. Kraft,et al.  Symptomatic fatigue in multiple sclerosis. , 1984, Archives of physical medicine and rehabilitation.

[10]  B. Weinshenker,et al.  A Randomized Controlled Trial of Amantadine in Fatigue Associated With Multiple Sclerosis , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[11]  J. Monks Experiencing symptoms in chronic illness: fatigue in multiple sclerosis. , 1989, International disability studies.